Randi Y. Leavitt

Best Publications

• Wegener granulomatosis : an analysis of 158 patients

  Gary S. Hoffman;Gail S. Kerr;Randi Y. Leavitt;Claire W. Hallahan

  3695
  Citations

• The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)

  Alfonse T. Masi;Alfonse T. Masi;Gene G. Hunder;Gene G. Hunder;J. T. Lie;J. T. Lie;Beat A. Michel

  2772
  Citations

• The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa

  Robert W. Lightfoot;Robert W. Lightfoot;Beat A. Michel;Daniel A. Bloch;Daniel A. Bloch;Gene G. Hunder;Gene G. Hunder

  1376
  Citations

• Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

  Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  1187
  Citations

• Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

  Jeffrey L. Lennox;Edwin DeJesus;Adriano Lazzarin;Richard B. Pollard

  838
  Citations

• Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.

  Unknown

  479
  Citations

• Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

  Joseph J Eron;Benjamin Young;David A Cooper;Michael Youle

  402
  Citations

• Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy

  Diane V. Havlir;Ian C. Marschner;Martin S. Hirsch;Ann C. Collier

  357
  Citations

• Wegener granulomatosis in children and adolescents: Clinical presentation and outcome

  Menachem Rottem;Anthony S. Fauci;Claire W. Hallahan;Gail S. Kerr

  348
  Citations

• Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

  Frances H. Priddy;Deborah Brown;James Kublin;Kathleen Monahan

  329
  Citations

• Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial

  Jeffrey L. Lennox;Raphael J. Landovitz;Heather J. Ribaudo;Ighovwerha Ofotokun

  325
  Citations

• Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.

  Jürgen K Rockstroh;Edwin DeJesus;Jeffrey L Lennox;Yazdan Yazdanpanah

  276
  Citations

• Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1-Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

  Jeffrey L. Lennox;Edwin DeJesus;Daniel S. Berger;Adriano Lazzarin

  270
  Citations

• Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.

  Gary S. Hoffman;Randi Y. Leavitt;Thomas A. Fleisher;James R. Minor

  266
  Citations

• Pneumocystis carinii pneumonia: A major complication of immunosuppressive therapy in patients with Wegener's granulomatosis

  Frederick P. Ognibene;James H. Shelhamer;Gary S. Hoffman;Gail S. Kerr

  264
  Citations

• The management of subglottic stenosis in patients with Wegener's granulomatosis.

  Robert S. Lebovics;Gary S. Hoffman;Randi Y. Leavitt;Gail S. Kerr

  230
  Citations

• Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

  Joseph J. Eron;Jürgen K. Rockstroh;Jacques Reynes;Jaime Andrade-Villanueva

  228
  Citations

• Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1–Infected Patients: 156-Week Results From STARTMRK

  Jürgen K. Rockstroh;Jeffrey L. Lennox;Edwin Dejesus;Michael S. Saag

  222
  Citations

• A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.

  Per Ljungman;Michael Schmitt;Francisco M Marty;Johan Maertens

  168
  Citations

• A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy

  Martin Hirsch;Roy Steigbigel;Scholomo Staszewski;John Mellors

  153
  Citations